Businesses selling non-FDA-approved stem cell products grew four-fold in five years, study says
Novel network improves accuracy of lymph node metastasis prediction in patients with T1 lung adenocarcinoma
4 November 2021What does long COVID feel like?
4 November 2021Businesses selling non-FDA-approved stem cell products grew four-fold in five years, study says
More than four times as many businesses and clinics than were identified in 2016 are selling stem cell products not approved by the U.S. Food and Drug Administration and lack convincing evidence of safety and efficacy, according to a five-year study conducted by University of California, Irvine Program in Public Health professor of health, society and behavior Leigh Turner. The analysis appears online in the journal Cell Stem Cell.
